- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2016
- Public Summary Document (PSD) March 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2016 PBAC Meeting - Word
Pomalidomide – March 2016
Pomalidomide: 3 mg capsule, 214 mg capsule, 21, Pomalyst®
Last updated
15 July 2016